Co-Authors
This is a "connection" page, showing publications co-authored by Donald Alcendor and Mohammad Tabatabai.
Connection Strength
1.117
-
Alcendor DJ, Matthews-Juarez P, Williams N, Wilus D, Tabatabai M, Hopkins E, George K, Leon AH, Santiago R, Lee A, Smoot D, Hildreth JEK, Juarez PD. COVID-19 Vaccine Hesitancy and Uptake among Minority Populations in Tennessee. Vaccines (Basel). 2023 Jun 07; 11(6).
Score: 0.230
-
Tabatabai MA, Bahri N, Matthews-Juarez P, Alcendor D, Cooper R, Juarez P, Ramesh A, Tabatabai N, Singh KP, Wilus D. The role of histological subtypes in the survival of patients diagnosed with cutaneous or mucosal melanoma in the United States of America. PLoS One. 2023; 18(6):e0286538.
Score: 0.230
-
Tabatabai M, Juarez PD, Matthews-Juarez P, Wilus DM, Ramesh A, Alcendor DJ, Tabatabai N, Singh KP. An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA. J Prim Care Community Health. 2023 Jan-Dec; 14:21501319231170164.
Score: 0.223
-
Alcendor DJ, Matthews-Juarez P, Smoot D, Hildreth JEK, Tabatabai M, Wilus D, Brown KY, Juarez PD. The COVID-19 Vaccine and Pregnant Minority Women in the US: Implications for Improving Vaccine Confidence and Uptake. Vaccines (Basel). 2022 Dec 12; 10(12).
Score: 0.222
-
Alcendor DJ, Matthews-Juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines (Basel). 2022 May 11; 10(5).
Score: 0.213